AFYREN, the innovative Greentech for sustainable chemistry, launches its IPO on Euronext Growth® in Paris
- A capital increase of approximately €70 million, which may be increased to above €80 million if the extension clause is exercised
- Indicative offering price range: €8.02 to €9.72 per share
- Subscription commitments of €32.66 million to €35.00 million from Bpifrance, Mirova, Sofinnova Biotech Partner 1 and Crédit Agricole Centre France Developpement
- French public offering closes on: 27 September 2021 (at 5.00pm over-the-counter and 8.00pm online)
- Global placement closes on: 28 September 2021 (at 12.00pm)
- Securities eligible for French SME equity savings plans (PEA-PME)
Clermont-Ferrand/Lyon, 14 September 2021 – AFYREN, a greentech company that offers manufacturers natural and low-carbon products produced using a technology based on natural micro-organisms, announces the launch of its IPO with a view to listing its shares on the Paris Euronext Growth® market (ISIN code: FR-0014005AC9 mnemonic: ALAFY).
On 13 September 2021, the French financial markets authority (AMF) approved, under number 21-397, the prospectus for the IPO of AFYREN, comprising the registration document, approved under number I. 21-042 and dated 25 August 2021, a securities note and a summary of the Prospectus (included in the securities note).
LATEST NEWS
Read our articles and press releases to find out more and discover the world of sustainable industry.
View all articles
Article : The future is regenerative: circular bioeconomy with fully sustainable solutions
Publication AFYREN obtains new financing of 9 million euros to support the start-up of AFYREN NEOXY
Press release
AFYREN awarded Silver Medal by ECOVADIS with an improved score
Press release
#INSPIRINGTALKS – Part 2 – How the lubricant industry took action to lower its carbon footprint – A discussion with Apu Gosalia, also known as “The Sustainalyst”
News post
AFYREN announces signing of new commercial contract with US nutraceutical maker
Press release AFYREN announces new initiation of coverage by Bryan, Garnier & Co
Press release